Inventor · disambiguated record
Rui Xu
Also filed as: XU RUI · XU RUI HENG
38 granted patents·29 pending applications·336 citations·filing 2001–2025
97Inventor score
Files withARRAY BIOPHARMA INC22PELOTON THERAPEUTICS INC12HANGZHOU POLYMED BIOPHARMACEUTICALS INC6MITCHELL IAN S6THERAS INC5
Top patents by PatentIndex Score
67 records- 0197US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 0295US10155726B2Substituted pyridines and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·14 cites·24 claims
- 0395US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0494US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 0593USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0693US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0793US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0893US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0993US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 1092US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 1190US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 1289US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1389US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 1488US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 1587US8329701B2Dihydrofuro pyrimidines as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Dec 11, 2012·12 cites·27 claims
- 1687US8329709B25H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 11, 2012·10 cites·33 claims
- 1786US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1883US12343343B2Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2024·Granted Jul 1, 2025·0 cites·3 claims
- 1982US8618097B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsBENCSIK JOSEF·Filed 2008·Granted Dec 31, 2013·7 cites·48 claims
- 2081US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 2181US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 2277US8853216B2Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitorBENCSIK JOSEF·Filed 2009·Granted Oct 7, 2014·3 cites·5 claims
- 2377US2022226326A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2477US2025152588A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2575US12281098B2Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and useHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2024·Granted Apr 22, 2025·0 cites·3 claims
- 2675US8846683B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Sep 30, 2014·1 cites·35 claims
- 2774US2025368627A1Pyrazolesulfonamides as antitumor agentsPELOTON THERAPEUTICS INC A FULLY OWNED SUBSIDIARY OF MERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2873US9409886B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Aug 9, 2016·2 cites·50 claims
- 2973US6503922B2Bridged nicotine compounds for use in the treatment of CNS pathologiesUNIV KENTUCKY RES FOUND·Filed 2001·Granted Jan 7, 2003·7 cites·36 claims
- 3072US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3171US9303040B2Substituted piperazines as AKT inhibitorsMITCHELL IAN S·Filed 2007·Granted Apr 5, 2016·1 cites·32 claims
- 3271US8895566B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 25, 2014·1 cites·34 claims
- 3371US8835434B2Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsBENCSIK JOSEF R·Filed 2009·Granted Sep 16, 2014·2 cites·2 claims
- 3471US2020345735A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3571US2025255864A1Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3671US2025255863A1Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3768US9546156B2N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jan 17, 2017·1 cites·25 claims
- 3864US2014315887A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 3964US2018169099A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 4063US7091357B2Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologiesUNIV KENTUCKY RES FOUND·Filed 2002·Granted Aug 15, 2006·4 cites·15 claims
- 4162US9328091B25H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted May 3, 2016·0 cites·3 claims
- 4260US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4360US2016235754A1Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 4459US12195479B2Five- and six-membered compound, and preparation method therefor and pharmaceutical composition and use thereofHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 4559US2022162193A1Pyrazolesulfonamides as antitumor agentsESTRADA MICHELLE ANN·Filed 2020·Application pending·0 cites
- 4658US7320857B2Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereofCHINESE NAT HUMAN GENOME CT SH·Filed 2004·Granted Jan 22, 2008·2 cites·6 claims
- 4758US2014349996A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 4857US2025214972A1Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and useHANGZHOU POLYMED BIOPHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4956US2016152576A9Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 5055US12378564B2Tomato glutaredoxin SIGRXC9 gene and its applicationSANYA INSTITUTE OF HENAN UNIV·Filed 2022·Granted Aug 5, 2025·0 cites·7 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →